Related Experiment Video
Updated: May 30, 2026
16:40
A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
[Psychocardiological practice guidelines for ICD implantation and long-term care].
1Abteilung für Psychokardiologie, Herz-, Thorax- und Rheumazentrum, Kerckhoff-Klinik, Benekestr. 2-8, 61231, Bad Nauheim, Deutschland. j.jordan@reha.kerckhoff-klinik.de
Herzschrittmachertherapie & Elektrophysiologie
|August 9, 2011
Summary
A significant number of patients experience anxiety and depression after ICD implantation. Early screening and targeted support are crucial for managing psychological distress and improving patient outcomes following cardiac device procedures.
Area of Science:
- Cardiology
- Psychology
- Medical Education
Context:
- Limited research exists on patient education post-implantable cardioverter-defibrillator (ICD) implantation.
- While most patients adapt well, approximately 20% experience anxiety and depression within the first year.
Purpose:
- To highlight the need for systematic patient education and psychological support after ICD implantation.
- To recommend early screening for anxiety and depression and tailored information delivery.
Summary:
- Routine screening using tools like the Hospital Anxiety and Depression Scale (HADS) upon discharge is advised.
- Follow-up appointments should allow patients to voice concerns, enabling early detection of mental stress.
- Patients experiencing multiple shocks may require psychocardiological consultation for potential post-traumatic disorders.
Impact:
- Implementing these recommendations can lead to timely recognition and treatment of psychological distress in ICD patients.
- Improved patient education and support can enhance cognitive acceptance and coping mechanisms.
- Proactive management of mental health issues post-ICD implantation is essential for overall patient well-being.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Endocarditis IV: Nursing Management
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...